arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Cadre Holdings, Inc.

CDRE
$32.83 ▼ -2.17 (-6.20%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
26 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Bullish
auto_awesome

Analytical Summary

Cadre Holdings, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.4B
Dividend Yield 0.30%
Revenue Growth 19.5%
Op. Margin 4.8%
ROIC 0.8%
FCF / Share $0.47
Trailing P/E 656.6x
Price / Book 4.2x
FCF Yield 1.4%
Debt / Equity 1.04
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$155.43M
↑ +19.5%
Net Income Profit after all expenses
$1.98M
↓ -78.6%
Operating Margin Operating profit as % of sales
4.8%
↓ -60.6% 59th
FCF / Share Free cash flow per share
$0.47
↑ +17.8%
Long-Term Debt Long-term obligations
$349.57M
↑ +20.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
58
Returns
78
Financial Health
50
Cash Quality
75

Dividend History

Dividend / share · sourced from SEC filings
$0.10 Latest / share
+8.6% YoY
+5.9% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters